MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabres

EQS-News: MorphoSys AG / Key word(s): ConferenceMorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting 24.04.2024 / 16:40 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, April...

Related Keywords

Massachusetts , United States , Boston , Illinois , Germany , Chicago , Planegg , Bayern , American , Kaitlyn Nealy , Julia Neugebauer , Thomas Biegi , Twitter , American Society Of Clinical Oncology , Nasdaq , Lymphoma Society , Constellation Pharmaceuticals Inc , Distribution Services , Linkedin , Corporate Affairs , Sys To Present New Phase , Oral Presentation , Clinical Oncology , Efficacy Data , Combination With Ruxolitinib , Patients With , Advanced Solid Tumors , Vice President , Global Head , Corporate News , Regulatory Announcements ,